US Penny Stocks: 3 Hidden Gems With Market Caps As Low As $4M

In This Article:

As the U.S. stock market takes a breather from recent record highs, investors are exploring diverse opportunities to capitalize on potential growth areas. Penny stocks, despite being an old term, continue to offer intriguing possibilities for those willing to look beyond the surface. These smaller or newer companies can provide a unique mix of value and growth potential when supported by robust financials, making them appealing options for discovering hidden gems in today's market landscape.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

Inter & Co (NasdaqGS:INTR)

$4.36

$1.96B

★★★★☆☆

BAB (OTCPK:BABB)

$0.85

$6.03M

★★★★★★

QuantaSing Group (NasdaqGM:QSG)

$3.08

$144.14M

★★★★★★

Imperial Petroleum (NasdaqCM:IMPP)

$2.97

$90.69M

★★★★★★

Golden Growers Cooperative (OTCPK:GGRO.U)

$4.50

$69.71M

★★★★★★

ZTEST Electronics (OTCPK:ZTST.F)

$0.24

$8.83M

★★★★★★

Permianville Royalty Trust (NYSE:PVL)

$1.5309

$51.48M

★★★★★★

RLX Technology (NYSE:RLX)

$1.83

$2.39B

★★★★★★

Zynerba Pharmaceuticals (NasdaqCM:ZYNE)

$1.30

$65.6M

★★★★★☆

CBAK Energy Technology (NasdaqCM:CBAT)

$0.9244

$84.37M

★★★★★☆

Click here to see the full list of 706 stocks from our US Penny Stocks screener.

Let's uncover some gems from our specialized screener.

Rapid Micro Biosystems

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Rapid Micro Biosystems, Inc. is a life sciences technology company that offers products for detecting microbial contamination in the manufacturing of pharmaceuticals, medical devices, and personal care products globally, with a market cap of $44.76 million.

Operations: The company's revenue is derived from its Systems and Related LIMS Connection Software, Consumables, and Services segment, totaling $26.17 million.

Market Cap: $44.76M

Rapid Micro Biosystems, Inc. is navigating the penny stock landscape with a market cap of US$44.76 million and reported revenues of US$26.17 million from its Systems and Related LIMS Connection Software, Consumables, and Services segment. Despite being unprofitable with increasing losses over five years, it maintains a solid cash position with short-term assets exceeding both short- and long-term liabilities significantly. The company is debt-free, has not diluted shareholders recently, and forecasts revenue growth of 18.45% annually while reaffirming its 2024 revenue guidance at US$27 million amidst stable weekly volatility in its stock price.